07.07.2014 Views

Chapter XII - 1451k - the University Offices - University of Cambridge

Chapter XII - 1451k - the University Offices - University of Cambridge

Chapter XII - 1451k - the University Offices - University of Cambridge

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

FUNDS, STUDENTSHIPS, PRIZES, LECTURESHIPS, ETC.<br />

975<br />

2. The Managers <strong>of</strong> <strong>the</strong> Fund shall be <strong>the</strong> Chairman <strong>of</strong> <strong>the</strong> John van Geest Centre for Brain Repair,<br />

<strong>the</strong> Head <strong>of</strong> <strong>the</strong> Department <strong>of</strong> Clinical Neurosciences, and a representative nominated by <strong>the</strong> Faculty<br />

Board <strong>of</strong> Clinical Medicine. The Managers may co-opt up to two more Managers as required. Coopted<br />

Managers shall be appointed in <strong>the</strong> Michaelmas Term to serve for four years from 1 January<br />

following <strong>the</strong>ir appointment.<br />

3. If and whenever <strong>the</strong> income <strong>of</strong> <strong>the</strong> Fund exceeds <strong>the</strong> amount required for <strong>the</strong> payment <strong>of</strong> <strong>the</strong><br />

stipend, national insurance, pension contributions, and associated indirect costs <strong>of</strong> <strong>the</strong> John van Geest<br />

Lectureship and <strong>the</strong> provision <strong>of</strong> <strong>the</strong> Gussy Marlowe Clinician Ph.D. Fellowship, <strong>the</strong> surplus shall be<br />

applied to support:<br />

(i) <strong>the</strong> work <strong>of</strong> <strong>the</strong> Lecturer;<br />

(ii) <strong>the</strong> work <strong>of</strong> <strong>the</strong> Fellow; and/or<br />

(iii) research in <strong>the</strong> Department <strong>of</strong> Clinical Neurosciences<br />

in such a manner as may be approved by <strong>the</strong> General Board <strong>of</strong> <strong>the</strong> Faculties on <strong>the</strong> recommendation<br />

<strong>of</strong> <strong>the</strong> Managers.<br />

4. (a) The Lecturer shall be appointed by <strong>the</strong> Appointments Committee for <strong>the</strong> Faculty <strong>of</strong> Clinical<br />

Medicine in <strong>the</strong> manner prescribed by Statute D, XVII, 2.<br />

(b) The Fellow shall be selected on <strong>the</strong> recommendation <strong>of</strong> <strong>the</strong> Graduate Committee <strong>of</strong> <strong>the</strong> Department<br />

<strong>of</strong> Clinical Neurosciences, and approved by <strong>the</strong> Managers. The Fellowship may be awarded to nonclinicians<br />

and to candidates who already have a higher degree with <strong>the</strong> approval <strong>of</strong> <strong>the</strong> Managers.<br />

5. Any unexpended income <strong>of</strong> <strong>the</strong> Fund in a financial year may, in any one or more subsequent<br />

years, be expended in accordance with Regulation 3 or added to <strong>the</strong> capital <strong>of</strong> <strong>the</strong> Fund.<br />

Managers.<br />

Application <strong>of</strong><br />

surplus income.<br />

Appointments.<br />

Unexpended<br />

income.<br />

VAN G EEST FOUNDATION FUND FOR BRAIN REPAIR AND NEUROSCIENCE<br />

Grace 1 <strong>of</strong> 3 August 2011<br />

1. The £500,000 benefaction received from <strong>the</strong> John and Lucille van Geest Foundation, shall form<br />

a fund to be entitled <strong>the</strong> Van Geest Foundation Fund for Brain Repair and Neuroscience, <strong>the</strong> income<br />

<strong>of</strong> which shall be used to support teaching and research in <strong>the</strong> School <strong>of</strong> Clinical Medicine, with a<br />

preference for brain repair and neuroscience; <strong>the</strong> Fund shall include any future benefactions received<br />

from <strong>the</strong> John and Lucille van Geest Foundation by way <strong>of</strong> additions <strong>the</strong>reto.<br />

2. The Managers <strong>of</strong> <strong>the</strong> Fund shall be <strong>the</strong> Head <strong>of</strong> <strong>the</strong> School <strong>of</strong> Clinical Medicine, <strong>the</strong> Head <strong>of</strong><br />

<strong>the</strong> Department <strong>of</strong> Clinical Neurosciences, and one o<strong>the</strong>r Manager appointed by <strong>the</strong> Council <strong>of</strong> <strong>the</strong><br />

School <strong>of</strong> Clinical Medicine for periods <strong>of</strong> five years.<br />

3. The income <strong>of</strong> <strong>the</strong> Fund shall be applied for <strong>the</strong> following purposes in <strong>the</strong> School <strong>of</strong> Clinical<br />

Medicine, with a preference for <strong>the</strong> fields <strong>of</strong> brain repair and neuroscience:<br />

(a) research purposes (including <strong>the</strong> funding <strong>of</strong> equipment and o<strong>the</strong>r capital items) in <strong>the</strong> School;<br />

(b) <strong>the</strong> funding <strong>of</strong> graduate studentships in <strong>the</strong> School;<br />

(c) <strong>the</strong> payment <strong>of</strong> <strong>the</strong> stipend, national insurance, pension contributions, and associated indirect<br />

costs <strong>of</strong> <strong>the</strong> holders <strong>of</strong> such named posts in <strong>the</strong> School as may be designated or established from<br />

time to time by <strong>the</strong> <strong>University</strong> or <strong>the</strong> General Board as a charge on <strong>the</strong> Fund.<br />

4. In exceptional circumstances <strong>the</strong> capital <strong>of</strong> <strong>the</strong> Fund may also be spent, on <strong>the</strong> recommendation<br />

<strong>of</strong> <strong>the</strong> Managers and with <strong>the</strong> approval <strong>of</strong> <strong>the</strong> General Board, for <strong>the</strong> purposes outlined in Regulation<br />

3 or to provide additional or new laboratory space needed for <strong>the</strong> fur<strong>the</strong>rance <strong>of</strong> such purposes.<br />

5. Any unexpended income <strong>of</strong> <strong>the</strong> Fund in a financial year may be added to <strong>the</strong> capital <strong>of</strong> <strong>the</strong> Fund;<br />

or retained for use as income in future years, as <strong>the</strong> Managers shall determine.<br />

Fund and title.<br />

Managers.<br />

Purposes.<br />

Unexpended<br />

income.<br />

VER HEYDEN DE LANCEY FUND<br />

1. The sum accumulated from <strong>the</strong> donations <strong>of</strong> <strong>the</strong> de Lancey and de la Hanty Foundation shall<br />

form a fund called <strong>the</strong> Ver Heyden de Lancey Fund, for <strong>the</strong> promotion <strong>of</strong> medico-legal studies in <strong>the</strong><br />

<strong>University</strong>.<br />

2. The Managers <strong>of</strong> <strong>the</strong> Fund shall be three persons appointed in <strong>the</strong> Michaelmas Term to serve for<br />

two years from 1 January following <strong>the</strong>ir appointment, as follows: one appointed by <strong>the</strong> General Board,<br />

who shall be Chairman, one by <strong>the</strong> Faculty Board <strong>of</strong> Clinical Medicine, and one by <strong>the</strong> Faculty Board<br />

<strong>of</strong> Law.<br />

Fund.<br />

Managers.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!